Page 1028 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 62

REFERENCES

1. Geroulanos S, Douka ET. Historical perspective of the word 18. De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L.
“sepsis”. Intensive Care Med. 2006;32:2077. Microvascular blood flow is altered in patients with sepsis.
2. Nduka OO, Parrillo JE. The pathophysiology of septic shock. Am J Respir Crit Care Med. 2002;166:98-104.
Crit Care Nurs Clin North Am. 2011;23(1):41-66. 19. Brealey D, Brand M, Hargreaves I, et al. Association between
3. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mecha- mitochondrial dysfunction and severity and outcome of septic
nisms in sepsis. Nature Rev Immunol. 2008;8:776-787. shock. Lancet. 2002;360:219-223.
4. Thomas L. Germs. N Engl J Med. 1972;287:553-555. 20. Protti A, Singer M. Bench-to-bedside review: potential strategies
to protect or reverse mitochondrial dysfunction in sepsis-induced
5. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure. Crit Care. 2006;10:228.
organ failure and guidelines for the use of innovative therapies
in sepsis. The ACCP/SCCM Consensus Conference Committee. 21. Calvano SE, Xiao W, Richards DR, et al. A network-based
American College of Chest Physicians/Society of Critical Care analysis of systemic inflammation in humans. Nature. 2005;
Medicine. Chest. 1992;101:1644-1655. 437:1032-1037.
6. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for 22. Suliman HB, Carraway MS, Piantadosi CA. Postlipopolysaccharide
pathogenesis of the disease process. Chest. 1997;112:235-243. oxidative damage of mitochondrial DNA. Am J Respir Crit Care
Med. 2003;167:570-579.
7. Reddy RC, Chen GH, Tekhandani TJ, et al. Sepsis-induced
immunosuppression: from bad to worse. Immunol Res. 23. Munford RS, Pugin J. Normal responses to injury prevent sys-
2001;24:273-287. temic inflammation and can be immunosuppressive. Am J Respir
8. Kaplan JK, Wong HR. Biomarker discovery and development Crit Care Med. 2001;163:316-321.
in pediatric critical care medicine. Pediatr Crit Care Med. 24. van der Poll T, Opal SM. Host-pathogen interactions in sepsis.
2011;12:165-170. Lancet Infect Dis. 2008;8:32-43.
9. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to 25. Hotchkiss RS, Karl IE. The pathophysiology and treatment of
treat sepsis and septic shock. Crit Care Med. 1997;25:1095-2011. sepsis. N Engl J Med. 2003;348:138-150.
10. Bone RC. Why sepsis trials fail. JAMA. 1996;276:565-566. 26. Annane D, Bellissant E, Cavaillon J-M. Septic shock. Lancet.
11. Schefold JC, Hasper D, Reinke P. Consider delayed immunosup- 2005;365:63-78.
pression into the concept of sepsis. Crit Care Med. 2008;36(11):3118 27. von Muller L, Klemm A, Durmus N, et al. Cellular immunity
12. American College of Chest Physicians/Society of Critical Care and active human cytomegalovirus infection in patients with
Medicine Consensus Conference. Definitions for sepsis and septic shock. J Infect Dis. 2007;196:1288-1295.
organ failure and guidelines for the use of innovative therapies 28. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus
in sepsis. Crit Care Med. 1992;20:864-874. reactivation in critically ill immunocompetent patients. JAMA.
13. Rudiger A, Martin Stotz M, Singer M. Cellular processes in 2008;300:413-422.
sepsis. Swiss Med Weekly. 2008;138(43-44):629-634. 29. Pugin J. Immunostimulation is a rational therapeutic strategy in
14. Cornell TT, Shanley TP. Signal transduction overview. Crit Care sepsis. Novartis Found Symp. 2007;280(21-36):160-164.
Med. 2005;33:S410-S413. 30. Hotchkiss RS, Opal S. Immunotherapy for sepsis—a
15. Zingarelli B. Nuclear factor-kappaB. Crit Care Med. 2005; new approach against an ancient foe. N Engl J Med. 2003;
33:S414-S416. 363:87-89.
16. Castellheim A, Brekke O-L, Espevik T, Harboe M. Mollnes TE. 31. Schefold JC, Hasper D, Volk HD, Reinke P. Sepsis: time has come
Innate immune responses to danger signals in systemic inflam- to focus on the later stages. Med Hypotheses. 2008;71:203-208.
matory response syndrome and sepsis. Scand J Immunol. 2009; 32. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J,
69:479-491. Pinsky MR. Epidemiology of severe sepsis in the United States:
17. Levy RM, Prince JM, Billiar TR. Nitric oxide: a clinical primer. analysis of incidence, outcome, and associated costs of care. Crit
Crit Care Med. 2005;33:S492-S495. Care Med. 2001;29:1303-1310.

Section05-O-ref.indd 1 1/20/2015 4:51:15 PM